End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 CNY | -2.25% |
|
+1.40% | -23.75% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- With an expected P/E ratio at 34.12 and 26.36 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-23.75% | 264M | - | ||
+0.91% | 204B | B | ||
+3.74% | 178B | B- | ||
+28.89% | 156B | B- | ||
+31.66% | 113B | A- | ||
+1.18% | 64.26B | A- | ||
+19.45% | 54.98B | B+ | ||
-3.44% | 47.44B | B+ | ||
-9.28% | 36.7B | A | ||
-0.10% | 34.84B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300562 Stock
- Ratings Guangdong Transtek Medical Electronics Co., Ltd